NVAX logo

Novavax (NVAX) Return On Equity

Annual ROE

76.03%
-27.73%-26.73%

December 31, 2023


Summary


Performance

NVAX ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXprofitabilitymetrics:

Quarterly ROE

44.82%
+1.12%+2.56%

September 30, 2024


Summary


Performance

NVAX Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

NVAX ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-26.7%-39.5%
3 y3 years+140.1%+113.0%
5 y5 years-30.9%-43.1%

NVAX ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-26.7%+106.0%-89.2%+103.1%
5 y5-year-26.7%+106.0%-89.2%+103.1%
alltimeall time-57.9%+106.0%-90.1%+102.8%

Novavax ROE History

DateAnnualQuarterly
Sep 2024
-
44.82%(+2.6%)
Jun 2024
-
43.70%(-17.3%)
Mar 2024
-
52.86%(-26.2%)
Dec 2023
76.03%(-26.7%)
71.59%(-3.4%)
Sep 2023
-
74.12%(-10.0%)
Jun 2023
-
82.35%(-55.2%)
Mar 2023
-
183.91%(+8.4%)
Dec 2022
103.76%(-108.2%)
169.61%(-59.3%)
Sep 2022
-
416.60%(-128.4%)
Jun 2022
-
-1465.25%(+335.9%)
Mar 2022
-
-336.18%(-2.8%)
Dec 2021
-1265.72%(+567.6%)
-345.77%(+91.7%)
Sep 2021
-
-180.39%(+2.7%)
Jun 2021
-
-175.72%(+10.5%)
Mar 2021
-
-159.08%(-46.1%)
Dec 2020
-189.60%(-365.8%)
-295.30%(-78.1%)
Sep 2020
-
-1346.17%(-877.0%)
Jun 2020
-
173.26%(+119.8%)
Mar 2020
-
78.82%(+5.7%)
Dec 2019
71.33%(-35.2%)
74.55%(-13.9%)
Sep 2019
-
86.59%(-22.7%)
Jun 2019
-
112.08%(-17.8%)
Mar 2019
-
136.32%(-11.1%)
Dec 2018
110.01%(-39.1%)
153.42%(-14.4%)
Sep 2018
-
179.31%(-12.7%)
Jun 2018
-
205.30%(-7.9%)
Mar 2018
-
222.86%(-19.9%)
Dec 2017
180.64%(-192.6%)
278.39%(-38.5%)
Sep 2017
-
452.85%(-128.3%)
Jun 2017
-
-1598.95%(+303.0%)
Mar 2017
-
-396.81%(+79.3%)
Dec 2016
-195.01%(+224.5%)
-221.33%(+47.5%)
Sep 2016
-
-150.08%(+50.1%)
Jun 2016
-
-99.99%(+55.6%)
Mar 2016
-
-64.27%(+37.3%)
Dec 2015
-60.10%(+56.8%)
-46.80%(+40.5%)
Sep 2015
-
-33.32%(+8.0%)
Jun 2015
-
-30.85%(-10.0%)
Mar 2015
-
-34.28%(-3.5%)
Dec 2014
-38.33%(+4.5%)
-35.53%(+25.3%)
Sep 2014
-
-28.35%(-10.7%)
Jun 2014
-
-31.73%(-13.8%)
Mar 2014
-
-36.82%(-8.4%)
Dec 2013
-36.68%(-13.7%)
-40.18%(-11.7%)
Sep 2013
-
-45.51%(-16.0%)
Jun 2013
-
-54.19%(+16.3%)
Mar 2013
-
-46.58%(+1.6%)
Dec 2012
-42.52%(+24.0%)
-45.85%(+8.2%)
Sep 2012
-
-42.38%(+17.7%)
Jun 2012
-
-36.01%(+2.0%)
Mar 2012
-
-35.30%(+1.1%)
Dec 2011
-34.30%(-38.0%)
-34.91%(-7.6%)
Sep 2011
-
-37.78%(-23.4%)
Jun 2011
-
-49.35%(-9.7%)
Mar 2011
-
-54.65%(-3.1%)
Dec 2010
-55.36%
-56.38%(-19.3%)
Sep 2010
-
-69.85%(+3.9%)
DateAnnualQuarterly
Jun 2010
-
-67.21%(-5.5%)
Mar 2010
-
-71.13%(-1.3%)
Dec 2009
-69.90%(+5.2%)
-72.05%(+8.0%)
Sep 2009
-
-66.69%(-8.2%)
Jun 2009
-
-72.68%(-3.8%)
Mar 2009
-
-75.57%(+12.2%)
Dec 2008
-66.42%(+50.0%)
-67.33%(+15.8%)
Sep 2008
-
-58.12%(+4.8%)
Jun 2008
-
-55.48%(+16.4%)
Mar 2008
-
-47.66%(+8.7%)
Dec 2007
-44.27%(+37.8%)
-43.86%(+19.7%)
Sep 2007
-
-36.65%(+22.7%)
Jun 2007
-
-29.87%(+13.5%)
Mar 2007
-
-26.32%(+4.0%)
Dec 2006
-32.12%(+19.2%)
-25.31%(+79.5%)
Sep 2006
-
-14.10%(+0.2%)
Jun 2006
-
-14.07%(-19.8%)
Mar 2006
-
-17.55%(-54.2%)
Dec 2005
-26.95%(-64.0%)
-38.29%(-61.2%)
Sep 2005
-
-98.77%(+2.7%)
Jun 2005
-
-96.15%(+1.1%)
Mar 2005
-
-95.13%(+22.5%)
Dec 2004
-74.89%(-4.6%)
-77.68%(+21.5%)
Sep 2004
-
-63.92%(-21.7%)
Jun 2004
-
-81.60%(+12.5%)
Mar 2004
-
-72.52%(-22.2%)
Dec 2003
-78.48%(-38.5%)
-93.21%(-29.8%)
Sep 2003
-
-132.86%(-7.5%)
Jun 2003
-
-143.60%(+5.4%)
Mar 2003
-
-136.22%(+9.7%)
Dec 2002
-127.63%(+288.4%)
-124.16%(+30.6%)
Sep 2002
-
-95.06%(+43.2%)
Jun 2002
-
-66.39%(+40.5%)
Mar 2002
-
-47.24%(+44.3%)
Dec 2001
-32.86%(-53.3%)
-32.73%(-24.1%)
Sep 2001
-
-43.11%(-16.3%)
Jun 2001
-
-51.53%(-15.7%)
Mar 2001
-
-61.11%(-20.3%)
Dec 2000
-70.42%(-54.6%)
-76.69%(-4.4%)
Sep 2000
-
-80.19%(+3.7%)
Jun 2000
-
-77.35%(-4.8%)
Mar 2000
-
-81.26%(-41.3%)
Dec 1999
-155.17%(+53.6%)
-138.55%(+23.4%)
Sep 1999
-
-112.29%(+47.7%)
Jun 1999
-
-76.05%(+16.4%)
Mar 1999
-
-65.33%(+14.1%)
Dec 1998
-101.05%(+30.2%)
-57.28%(+28.8%)
Sep 1998
-
-44.47%(-1.3%)
Jun 1998
-
-45.05%(-3.8%)
Mar 1998
-
-46.84%(-23.4%)
Dec 1997
-77.59%(-28.1%)
-61.11%(-20.7%)
Sep 1997
-
-77.03%(-3.1%)
Jun 1997
-
-79.51%(-10.7%)
Mar 1997
-
-89.00%(-11.8%)
Dec 1996
-107.84%
-100.92%(+56.1%)
Sep 1996
-
-64.67%(+46.7%)
Jun 1996
-
-44.07%(+131.3%)
Mar 1996
-
-19.05%

FAQ

  • What is Novavax annual return on equity?
  • What is the all time high annual ROE for Novavax?
  • What is Novavax annual ROE year-on-year change?
  • What is Novavax quarterly return on equity?
  • What is the all time high quarterly ROE for Novavax?
  • What is Novavax quarterly ROE year-on-year change?

What is Novavax annual return on equity?

The current annual ROE of NVAX is 76.03%

What is the all time high annual ROE for Novavax?

Novavax all-time high annual return on equity is 180.64%

What is Novavax annual ROE year-on-year change?

Over the past year, NVAX annual return on equity has changed by -27.73% (-26.73%)

What is Novavax quarterly return on equity?

The current quarterly ROE of NVAX is 44.82%

What is the all time high quarterly ROE for Novavax?

Novavax all-time high quarterly return on equity is 452.85%

What is Novavax quarterly ROE year-on-year change?

Over the past year, NVAX quarterly return on equity has changed by -29.30% (-39.53%)